007, I hope you are wrong about another boring year ahead. In 2023 I expect fda clearance will be received for iTrack Advance and am hopeful a funding partner will be found for the proposed 2RT trial. There is a major unmet need and we have good evidence that the 2RT is effective for a subgroup of the LEAD trial participants. I am confident this will get commercialized but agree it is progressing slowly. Hopefully we will get a positive announcement next year that will shock both of us!
I have been in this for many years and will continue to hold and will add on positive news.
EYE Nova Eye Medical price pop, page-5
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $51.48M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.8¢ | $137.7K | 624.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27766 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 34529 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.0¢ |
Change
0.010 ( 2.33 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 22.5¢ | 21.5¢ | 190801 | ||
| Last updated 15.47pm 14/06/2024 ? | |||||
| EYE (ASX) Chart |